Comparative Pharmacology
Head-to-head clinical analysis: OXACILLIN SODIUM versus VEETIDS.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OXACILLIN SODIUM versus VEETIDS.
OXACILLIN SODIUM vs VEETIDS
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Oxacillin is a penicillinase-resistant beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby blocking the transpeptidation step in peptidoglycan cross-linking. It is resistant to staphylococcal beta-lactamase.
VEETIDS (generic: voretigene neparvovec) is an adeno-associated virus vector-based gene therapy that delivers a functional copy of the RPE65 gene to retinal pigment epithelial cells, restoring the visual cycle and improving vision in patients with biallelic RPE65 mutation-associated retinal dystrophy.
1-2 grams IV every 4-6 hours.
500 mg orally twice daily for 7-14 days.
None Documented
None Documented
0.3-0.8 hours in adults with normal renal function; prolonged to 1-2 hours in neonates and 2-5 hours in patients with severe renal impairment (CrCl <10 mL/min)
Terminal elimination half-life is 1.5-2 hours in adults with normal renal function; extends to 6-10 hours in moderate renal impairment.
Renal (70-80% unchanged by tubular secretion and glomerular filtration); biliary (minor, approximately 10%)
Renal elimination (60-80% unchanged); biliary/fecal excretion accounts for 15-20%.
Category A/B
Category C
Penicillin Antibiotic
Penicillin Antibiotic